-55.4%
APP vs MRNA
+945.0%
-1,000.4%
-68.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +10.7% | +13.1% | -2.4% | +10.2% |
| 7D | +4.5% | +20.6% | -16.1% | +3.8% |
| 30D | -3.6% | +27.1% | -30.8% | -4.5% |
| 3M | -35.3% | +353.4% | -388.6% | -40.2% |
| 6M | -42.8% | +446.3% | -489.0% | -48.7% |
| YTD | -59.7% | +776.2% | -835.8% | -64.6% |
| 1Y | -55.4% | +987.9% | -1,043.3% | -60.1% |
| All | -55.4% | +945.0% | -1,000.4% | -60.1% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling